|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ramalingam SS, Owonikoko TK and Khuri FR:
Lung cancer: New biological insights and recent therapeutic
advances. CA Cancer J Clin. 61:91–112. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Paz-Ares L: Beyond first-line NSCLC
therapy: Chemotherapy or erlotinib? Lancet Oncol. 13:225–227. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Geng GJ, Yang YT, Jiang J, Yu XY and Fa
XE: MicroRNA-30a suppresses non-small-cell lung cancer by targeting
Myb-related protein B. Exp Ther Med. 15:1633–1639. 2018.PubMed/NCBI
|
|
5
|
Peng H, Talebzadeh-Farrooji M, Osborne MJ,
Prokop JW, McDonald PC, Karar J, Hou Z, He M, Kebebew E, Orntoft T,
et al: LIMD2 is a small LIM-only protein overexpressed in
metastatic lesions that regulates cell motility and tumor
progression by directly binding to and activating the
integrin-linked kinase. Cancer Res. 74:1390–1403. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cerutti JM, Oler G, Michaluart P Jr,
Delcelo R, Beaty RM, Shoemaker J and Riggins GJ: Molecular
profiling of matched samples identifies biomarkers of papillary
thyroid carcinoma lymph node metastasis. Cancer Res. 67:7885–7892.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang X, Tang S, Le SY, Lu R, Rader JS,
Meyers C and Zheng ZM: Aberrant expression of oncogenic and
tumor-suppressive microRNAs in cervical cancer is required for
cancer cell growth. PLoS One. 3:e25572008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu H, Lei C, He Q, Pan Z, Xiao D and Tao
Y: Nuclear functions of mammalian MicroRNAs in gene regulation,
immunity and cancer. Mol Cancer. 17:642018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xie F, Huang Q, Liu CH, Lin XS, Liu Z, Liu
LL, Huang DW and Zhou HC: MiR-1271 negatively regulates AKT/MTOR
signaling and promotes apoptosis via targeting PDK1 in pancreatic
cancer. Eur Rev Med Pharmacol Sci. 22:678–686. 2018.PubMed/NCBI
|
|
10
|
Xia D, Tian S, Chen Z, Qin W and Liu Q:
miR302a inhibits the proliferation of esophageal cancer cells
through the MAPK and PI3K/Akt signaling pathways. Oncol Lett.
15:3937–3943. 2018.PubMed/NCBI
|
|
11
|
Xie Y, Zhang H, Guo XJ, Feng YC, He RZ, Li
X, Yu S, Zhao Y, Shen M, Zhu F, et al: Let-7c inhibits
cholangiocarcinoma growth but promotes tumor cell invasion and
growth at extrahepatic sites. Cell Death Dis. 9:2492018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang N, Zhang Y and Liang H: microRNA-598
inhibits cell proliferation and invasion of glioblastoma by
directly targeting metastasis associated in colon cancer-1. Oncol
Res. Feb 14–2018.(Epub ahead of print). View Article : Google Scholar
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(T)(-Delta Delta C) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pinheiro Dos, Santos MJC, Bastos AU, da
Costa VR, Delcelo R, Lindsey SC, Colozza-Gama GA, Peng H, Rauscher
FJ III, Oler G and Cerutti JM: LIMD2 is overexpressed in BRAF
V600E-positive papillary thyroid carcinomas and matched lymph node
metastases. Endocr Pathol. 29:222–230. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tong X, Wang X, Wang C and Li L: Elevated
levels of serum MiR-152 and miR-24 in uterine sarcoma: Potential
for inducing autophagy via SIRT1 and deacetylated LC3. Br J Biomed
Sci. 75:7–12. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
You Y, Tan J, Gong Y, Dai H, Chen H, Xu X,
Yang A, Zhang Y and Bie P: MicroRNA-216b-5p Functions as a
Tumor-suppressive RNA by Targeting TPT1 in pancreatic cancer cells.
J Cancer. 8:2854–2865. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cao J, Yan XR, Liu T, Han XB, Yu JJ, Liu
SH and Wang LB: MicroRNA-552 promotes tumor cell proliferation and
migration by directly targeting DACH1 via the Wnt/β-catenin
signaling pathway in colorectal cancer. Oncol Lett. 14:3795–3802.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang M, Huang S and Long D: MiR-381
inhibits migration and invasion in human gastric carcinoma through
downregulatedting SOX4. Oncol Lett. 14:3760–3766. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhao S, Gao X, Zang S, Li Y, Feng X and
Yuan X: MicroRNA-383-5p acts as a prognostic marker and inhibitor
of cell proliferation in lung adenocarcinoma by cancerous inhibitor
of protein phosphatase 2A. Oncol Lett. 14:3573–3579. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Qiao W, Cao N and Yang L: MicroRNA-154
inhibits the growth and metastasis of gastric cancer cells by
directly targeting MTDH. Oncol Lett. 14:3268–3274. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Song C, Lu P, Sun G, Yang L and Wang Z and
Wang Z: miR-34a sensitizes lung cancer cells to cisplatin via
p53/miR-34a/MYCN axis. Biochem Biophys Res Commun. 482:22–27. 2017.
View Article : Google Scholar : PubMed/NCBI
|
